A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Clinical trial NCT06997497 · RECRUITING

Trial details

NCT number: NCT06997497
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Colon Adenocarcinoma Rectal Adenocarcinoma

Start date: 2025-07-16
Primary completion: 2029-03-28
Enrollment: 477

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.